Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $649.10M.
ENTERPRISE VALUE (EV)
$649.10M
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$649.10M
Enterprise Value (EV)
$649.10M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $649.10M | $649.10M |
| ACNB Corporation (ACNB)vs › | $651.32M | N/A |
| Capital Bancorp, Inc. (CBNK)vs › | $651.85M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $637.82M | N/A |
| American Bitcoin Corp (ABTC)vs › | $635.10M | N/A |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $633.40M | N/A |
| Hypoport SE (HYPOF)vs › | $630.67M | N/A |
| Gladstone Investment Corporation (GAINI)vs › | $669.58M | N/A |
| Donegal Group Inc. (DGICA)vs › | $672.06M | N/A |
| Coastal Financial Corporation (CCB)vs › | $624.44M | N/A |
Market Cap
$649.10M
Total Debt
$0.00
Cash
$223.00
Enterprise Value
$649.10M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
